These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Renal function decrement in type 2 diabetes mellitus patients in Cipto Mangunkusumo Hospital.
    Author: Triyanti K, Suhardjono, Soewondo P, Shatri H.
    Journal: Acta Med Indones; 2008 Oct; 40(4):192-200. PubMed ID: 19530368.
    Abstract:
    AIM: to screen for reduction of renal function in type 2 diabetes mellitus (DM) patients based on various estimated Glomerular Filtration rate (eGFR). METHODS: 1283 newly registered type 2 DM patients were included in the study room from the year 2003 until 2006. We calculated the eGFR by the Cockroft-Gault (CG), Cockroft-Gault adjusted for body surface area (CG-BSA), 4-variables Modification of Diet in Renal Disease (MDRD), and Chinese adapted MDRD (C-MDRD) methods based on serum creatinine. We also investigated the significant risk factors based on the method with the highest percentage of renal dysfunction. RESULTS: type 2 DM patients with serum creatinine > or = 2 mg/dL (the abnormal limit in Indonesia) was only 5.8%, but the prevalence of patients with eGFR<60mL/mnt was 36.1% (CG), 43.7% (CG-BSA), 13.2% (MDRD), or 22.8% (C-MDRD). We used CG-BSA to determine risk factors as the highest method with highest percentage of renal dysfunction. Significant risk factors for renal dysfunction based on multivariate analysis were history of hypertension (P=0.025, 95%Cl 1.08-3.19), proteinuria (P=0.015, 95%Cl 1.13-3.22), and diabetic retinopathy (P=0.001, 95% Cl 1.43-4.20). CONCLUSION: the use of eGFR is recommended to screen in type 2 DM patients than the use of mere serum creatinine. We advocate the use of CG-BSA method to increase the physician's awareness, as more subjects will fall within the ambit of CKD.
    [Abstract] [Full Text] [Related] [New Search]